Jeff has over 25 years’ experience in the bio-pharmaceutical industry including positions at Merck, Roche, Theravance and Cytokinetics. He has expertise in molecular pharmacology, in vivo pharmacology and translational research with industrial experience that includes leadership of discovery, preclinical and clinical development projects.
Jeff is a co-founder of Altos Therapeutics developing gastrointestinal therapeutics (acquired by Takeda Pharmaceuticals in March 2017). His academic activities include over 18 years as member of the Editorial Board for the “American Journal of Physiology: Cell Physiology” and 12 years instructing the “Molecular Pharmacology” course for the University of California, Berkeley Extension. Jeff has published over 50 scientific articles in peer-reviewed journals. He completed his bachelor’s degree in Chemistry at Cal Poly, San Luis Obispo, his Ph.D. in Pharmacology at UCSD and his postdoctoral training at Stanford University.